NEU 3.15% $21.27 neuren pharmaceuticals limited

I agree hottod.Even though NEU was hammered as collateral damage...

  1. 1,937 Posts.
    lightbulb Created with Sketch. 34
    I agree hottod.

    Even though NEU was hammered as collateral damage of the Culper report, I can't get my mind around NEU being the resultant target.

    The Aussie market generally is too small for US players to even bother dipping their toes in, let alone a stock as illiquid (relatively) as NEU.

    From the numbers you posted, it's likely there was a ACAD short built over a period, then outsized prior to the release of the Culper report.

    If they're any good at their game, they'd have covered on the large volume spike and -8% drop following report release.

    They are likely (IMO) onto their next target by now and won't give ACAD a second thought I'm afraid. Chalk up a small win for them and try again elsewhere.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.